Skip to main content

Find Clinical Trials

Home
Conditions
Pancreatic Diseases

Clinical trial condition

Pancreatic Diseases

Explore clinical trials studying Pancreatic Diseases. Study availability and eligibility vary by location and protocol.

4,382 public trials 841 recruiting studies

Refine in advanced search Browse all conditions

Pancreatic Diseases trial results

Completed

Phase I Randomized Study of CPX for the Treatment of Adult Patients With Mild Cystic Fibrosis

NCT00004428

Conditions: Congenital, Hereditary, and Neonatal Diseases and Abnormalities, Cystic Fibrosis, Digestive System Diseases, +9 more
Locations: Not specified

View Trial Details

Completed

Study of Ibuprofen to Preserve Lung Function in Patients With Cystic Fibrosis

NCT00004440

Conditions: Congenital, Hereditary, and Neonatal Diseases and Abnormalities, Cystic Fibrosis, Digestive System Diseases, +9 more
Locations: Not specified

View Trial Details

Completed

Randomized Study of Alendronate in Adult Patients With Cystic Fibrosis Related Osteoporosis

NCT00004489

Conditions: Bone Diseases, Bone Diseases, Metabolic, Congenital, Hereditary, and Neonatal Diseases and Abnormalities, +15 more
Locations: University of North Carolina School of Medicine Chapel Hill, North Carolina, United States

View Trial Details

Completed

NEOadjuvant Gemcitabine/Oxaliplatin Plus Adjuvant Gemcitabine in Resectable PAncreatic Cancer

NCT01521702

Conditions: Adenocarcinoma, Carcinoma, Digestive System Diseases, +10 more
Locations: Institut Paoli Calmettes Marseille, France

View Trial Details

Completed

Pilot Study of Behavioural Intervention for Nutrition in Cystic Fibrosis

NCT01957072

Conditions: Body Weight, Congenital, Hereditary, and Neonatal Diseases and Abnormalities, Cystic Fibrosis, +8 more
Locations: Northern General Hospital, Sheffield Teaching Hospitals NHS Foundation Trust Sheffield, South Yorkshire, United Kingdom

View Trial Details

Completed

Enzyme Suppletion in Exocrine Pancreatic Dysfunction

NCT01430234

Conditions: Chronic Disease, Chronic Pancreatitis, Digestive System Diseases, +7 more
Locations: Erasmus Medical Center Rotterdam, South Holland, Netherlands

View Trial Details

Completed

A Study to Evaluate the Efficacy and Safety of Simtuzumab Combined With Gemcitabine for Metastatic Pancreatic Adenocarcinoma

NCT01472198

Conditions: Digestive System Diseases, Digestive System Neoplasms, Endocrine Gland Neoplasms, +6 more
Locations: Birmingham Hematology and Oncology Associates, LLC Birmingham, Alabama, United States

University of South Alabama Mitchell Cancer Institute Mobile, Alabama, United States

Central Hematology Oncology Medical Group, Inc. Alhambra, California, United States

Comprehensive Blood and Cancer Center Bakersfield, California, United States

View all 57 locations

View Trial Details

Completed

Phase 1 Study Assessing the Safety and Tolerability of CTX-4430 in Cystic Fibrosis Patients

NCT01944735

Conditions: Congenital, Hereditary, and Neonatal Diseases and Abnormalities, Cystic Fibrosis, Digestive System Diseases, +5 more
Locations: The Medicinces Evaluation Unit Wythenshawe, Manchester, United Kingdom

Celerion Belfast, Northern Ireland, United Kingdom

Glasgow Clinical Research Facility Glasgow, United Kingdom

Royal Brompton Hospital London, United Kingdom

View Trial Details

Completed

Role of Octreotide in Preventing Pancreatic Fistula After Pancreaticoduodenectomy (PD) in Patients With Soft Pancreas

NCT01301222

Conditions: Digestive System Diseases, Digestive System Fistula, Fistula, +4 more
Locations: PVS Memorial Hospital Kochi, Kerala, India

View Trial Details

Completed

A Study in Adult and Pediatric Patients With Cystic Fibrosis

NCT00034515

Conditions: Congenital, Hereditary, and Neonatal Diseases and Abnormalities, Cystic Fibrosis, Digestive System Diseases, +5 more
Locations: Not specified

View Trial Details